PRESS RELEASE published on 04/24/2023 at 08:30, 1 year 5 months ago Aquis Stock Exchange: Restoration to Trading
PRESS RELEASE published on 04/21/2023 at 08:00, 1 year 5 months ago Aquis Stock Exchange: Admission to Trading
PRESS RELEASE published on 04/12/2023 at 08:00, 1 year 5 months ago Aquis Stock Exchange: Admission to trading
PRESS RELEASE published on 04/05/2023 at 08:00, 1 year 5 months ago Aquis Stock Exchange: Application for Admission Announcement
PRESS RELEASE published on 04/03/2023 at 08:00, 1 year 5 months ago Aquis Stock Exchange: Suspension of Trading
PRESS RELEASE published on 03/31/2023 at 08:00, 1 year 5 months ago Aquis Stock Exchange: Withdrawal from Trading
PRESS RELEASE published on 03/17/2023 at 15:15, 1 year 6 months ago Aquis Stock Exchange: Withdrawal from Trading
PRESS RELEASE published on 03/17/2023 at 08:00, 1 year 6 months ago Aquis Stock Exchange: Withdrawal from Trading
PRESS RELEASE published on 03/17/2023 at 08:00, 1 year 6 months ago Aquis Stock Exchange: Admission to Trading
PRESS RELEASE published on 03/13/2023 at 08:00, 1 year 6 months ago Aquis Stock Exchange: Admission to Trading
Published on 09/28/2024 at 02:06, 23 hours 27 minutes ago Global Education Communities Corp. Reports Second Tranche Closing of Non-Brokered Private Placement
Published on 09/28/2024 at 02:00, 23 hours 33 minutes ago Quantum Biopharma Provides Corporate Update
Published on 09/28/2024 at 02:00, 23 hours 33 minutes ago bettermoo(d)’s Moodrink(TM) Featured in Banners of Well-Known Canadian Retailers
Published on 09/28/2024 at 00:10, 1 day 1 hour ago LQWD Technologies Announces Non-Brokered Private Placement Update
Published on 09/28/2024 at 14:01, 11 hours 32 minutes ago Turkiye Garanti Bankasi A.S.: Explanation on Subordinated Debt Securities to Qualified Investors
Published on 09/27/2024 at 22:30, 1 day 3 hours ago DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Published on 09/27/2024 at 21:56, 1 day 3 hours ago EQS-Adhoc: FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz)
Published on 09/27/2024 at 18:50, 1 day 6 hours ago PETROFAC ANNOUNCES IN-PRINCIPLE AGREEMENT ON FINANCIAL RESTRUCTURE
Published on 09/27/2024 at 18:40, 1 day 6 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/27/2024 at 17:45, 1 day 7 hours ago NFL BIOSCIENCES: 2024 FIRST-HALF BUSINESS AND EARNINGS UPDATE
Published on 09/26/2024 at 18:00, 2 days 7 hours ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2024
Published on 09/26/2024 at 18:00, 2 days 7 hours ago GUILLEMOT CORPORATION: 2024 CONSOLIDATED INTERIM RESULTS
Published on 09/26/2024 at 17:47, 2 days 7 hours ago imerys-26-September-2024-information-share-capital-and-voting-rights-as-of-31-August-2024